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Abstract
Hyperoxia is common practice in the acute management of circulatory shock, and observational studies report that
it is present in more than 50 % of mechanically ventilated patients during the first 24 h after intensive care unit
(ICU) admission. On the other hand, “oxygen toxicity” due to the increased formation of reactive oxygen species
limits its use due to serious deleterious side effects. However, formation of reactive oxygen species to boost
bacterial killing is one of the body’s anti-microbial auto-defense mechanisms and, hence, O2 has been referred to as
an antibiotic. Consequently, hyperoxia during the peri-operative period has been advocated for surgical patients in
order to reduce surgical site infection. However, there is ample evidence that long-term exposure to hyperoxia
impaired bacterial phagocytosis and thereby aggravated both bacterial burden and dissemination. Moreover, a
recent retrospective study identified the number of days with hyperoxia, defined as a PaO2 > 120 mmHg only, as an
independent risk factor of ventilator-associated pneumonia in patients needing mechanical ventilation for more
than 48 h. Since so far the optimal oxygenation target is unknown for ICU patients, “conservative” O2 therapy
represents the treatment of choice to avoid exposure to both hypoxemia and excess hyperoxemia.
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Background
Despite recent evidence that “conservative” oxygenation
targets are safe [1, 2], hyperoxia is frequently present in
the intensive care unit (ICU) [3, 4]. O2 has friend-and-
foe properties because it is vital for ATP production and
toxic due to its oxidant effects [5]. On the one hand, “…
administration of oxygen should be started immediately to
increase O2 delivery…” during the management of circula-
tory shock in order to counteract the pathognomonic “…
imbalance between O2 supply and requirements…” [6].
On the other hand, oxygen toxicity arises from the forma-
tion of reactive oxygen species (ROS), in particular during
hypoxia/re-oxygenation, e.g., during shock resuscitation.
ROS themselves share the janus-headed character of O2:
they are vital signaling molecules and their increased
release to boost bacterial killing is one of the body’s anti-
microbial auto-defense mechanisms [7]. ROS formation is
directly related to the PO2 [5] and, hence, O2 was already
described as an antibiotic three decades ago [5]. Again,
there is contrasting experimental evidence: long-term
(48–96 h) exposure to PaO2 values >350–400 mmHg
aggravated the pulmonary bacterial burden and the
bacteria dissemination [8] due to impaired bacterial
phagocytosis and endotoxin-induced cytokine release.
Interestingly, ROS scavengers dose-dependently restored
the bactericidal capacity.
Hyperoxia during the peri-operative period was
reported to reduce post-operative wound infection. Pure
O2 ventilation attenuated the anesthesia- and surgery-
induced impairment of the phagocytic and microbicidal
capacity of alveolar macrophages in healthy patients
undergoing prolonged (>6 up to 10 h) elective surgery
[9]. The most recent meta-analysis (>8000 patients in 17
randomized control trials (RCTs)) concluded that hyperoxia
significantly decreases the risk of surgical site infection
during colorectal surgery [10]. Nevertheless, this approach
remains highly controversial due to the “moderate
evidence” [10] and the deleterious long-term complications
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reported in patients with cancer [11] and/or cardiovascular
disease [12]. Moreover, the question remains unanswered
whether hyperoxia affects host defense in mechanically
ventilated ICU patients in general: using a multivariate ana-
lysis of retrospective data on patients needing mechanical
ventilation for >48 h, Six et al. recently identified the num-
ber of days with hyperoxia as an independent risk factor of
ventilator-associated pneumonia (VAP) [13].
Hyperoxia, lung function, and O2 transport
Hyperoxia impairs pulmonary gas exchange due to inhib-
ition of hypoxic pulmonary vasoconstriction and adsorption
atelectasis [5]. Moreover, under healthy conditions blood O2
content only modestly increases upon switching from air to
pure O2 breathing due to the near-complete arterial
hemoglobin O2 saturation (SaO2) at PaO2 = 90–100 mmHg
[5]. Hence, the lower the hemoglobin content, the more
pronounced the effect of hyperoxia on blood O2 content,
such that hyperoxia may be helpful during hemorrhage [5].
However, any hyperoxia-related rise in blood O2 content
may at least in part be counterbalanced by a hyperoxia-
induced fall in cardiac output resulting from decreased heart
rate and increased systemic vascular resistance, the latter
being particularly pronounced in the cerebral and coronary
vasculature [5].
The acute hyperoxia-induced impairment of gas ex-
change must be discriminated from pulmonary O2 toxicity,
which presents as pulmonary inflammation and, ultimately,
hemorrhagic pulmonary edema [5]. This effect is well-
established after long-term hyperoxic exposures and/or
when combined with injurious ventilation. The only data in
mechanically ventilated patients originate from hyperoxia
over 14 h to 30 days and, given the publication year (1972),
lung-protective ventilation most likely was not used [5].
Hyperoxia and secondary pulmonary infection
The study by Six et al. [13] clearly suggests an associ-
ation between hyperoxia and VAP. Of note, hyperoxia
was defined as a PaO2 > 120 mmHg, in other words, a
PaO2 that is commonly observed in ICU patients [3, 4].
Moreover, the authors showed not only that the num-
bers of days with hyperoxia, but also “hyperoxemia at
ICU admission”, in other words, deliberate, iatrogenic
pre-ICU hyperoxia, was an independent risk factor of
VAP. Clearly, patients with VAP were older, sicker, and,
in particular, more frequently in shock prior to ICU ad-
mission. First, shock, as the dysbalance between tissue
O2 supply and demand leads to tissue hypoxia, which in
turn triggers hyper-inflammation that is aimed to clear
pathogens [14]. However, when “too pronounced and/or
sustained”, tissue hypoxia may cause anti-inflammation,
thereby rendering patients more susceptible to second-
ary infection [14]. Second, shock is defined as arterial
hypotension and/or the need for vasopressor use. Hence,
in the study by Six et al., patients with VAP most likely
received catecholamines more frequently, for a longer
period, and/or at higher doses. Exogenous catechol-
amines can impair both innate and adaptive immunity
and thereby increase bacterial growth and virulence.
Despite these potential limits and confounding factors,
the study by Six et al. raises an important question with
respect to the use of hyperoxia, i.e., whether there is an
optimal PaO2 target in the ICU. So far, only retrospect-
ive data are available yielding a U-shaped relationship
between mortality and arterial PO2, with a nadir at PaO2
values of 110–150 mmHg [3] and 150–200 mmHg [15].
Mortality sharply increased at PaO2 < 65 mmHg and
>225 mmHg [3]. However, another study found that
even PaO2 > 300 mmHg did not affect outcome, while
confirming the harmful impact of PaO2 < 65 mmHg [4].
Consequently, despite a strong signal suggesting an asso-
ciation between hyperoxia and poor hospital outcome,
the most recent meta-analyses on hyperoxia [16, 17] are
inconclusive due to the high data heterogeneity.
Conclusions
Hyperoxia is common practice during shock manage-
ment based on experimental evidence that correcting
oxygen debt is crucial for survival. On the other hand,
oxygen toxicity limits its use, especially during hypoxia/
re-oxygenation and/or long-term administration (i.e.,
>12–24 h). The data of the RCT “Optimal Oxygenation
in the Intensive Care Unit (O2-ICU)” (NCT02321072)
comparing PaO2 targets of 120 versus 75 mmHg in ICU
patients and the detailed results of the preliminary ter-
minated 2 × 2-factorial RCT “Hyperoxia and Hypertonic
Saline in Septic Shock (Hyper2S)” (NCT01722422),
simultaneously comparing target SaO2 88–95 % versus
pure O2 ventilation during the first 24 h and isotonic
versus hypertonic saline, are therefore eagerly awaited.
The results may allow finding criteria for “…a personal-
ized O2 target…in critically ill patients” [14]. Until then,
conservative O2 therapy [1, 2] should be the treatment
of choice to avoid both hypoxemia and excess hyperoxia.
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